Sr. VP, Pharmaceutical Development
Veralox Therapeutics
Henry Flanner, ME is Senior Vice President of Pharmaceutical Development at Veralox Therapeutics Inc. He has 29 years of industry experience in the development of small molecules. Over that time he has had a wide range of responsibilities including ADMET, PK and CMC. He is co-author of the paper disclosing the dissoltion fit factors f1 and f2.